DULUTH, Ga. — Boehringer Ingelheim U.S. Animal Health announced on Apr. 22 that its poultry vaccine site in Gainesville, Ga., has received carbon neutral certification, the first of its U.S. sites to earn this designation.
The site, which produces nearly 60 billion poultry vaccines every year, is Boehringer Ingelheim's first major manufacturing facility site in the U.S. and its third site globally to become carbon neutral.
“Boehringer Ingelheim is committed to making the company, surrounding communities, and the world more environmentally sustainable, now and for future generations,” said Randolph Legg, president and head of commercial business at. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
